ALB and liver disorder: The American Association for the Study of Liver Diseases (AASLD) recommends the infusion of human albumin in conjunction with LVPs to prevent PPCD and related complications including renal impairment, owing to albumin’s intravascular volume expansion properties to preserve effective arterial blood volume and its hypothesized role in controlling systemic inflammation.5